Literature DB >> 21506519

Quantitative measurement of JWH-018 and JWH-073 metabolites excreted in human urine.

Cindy L Moran1, Vi-Huyen Le, Krishna C Chimalakonda, Amy L Smedley, Felisia D Lackey, Suzanne N Owen, Paul D Kennedy, Gregory W Endres, Fred L Ciske, James B Kramer, Andrei M Kornilov, L D Bratton, Paul J Dobrowolski, William D Wessinger, William E Fantegrossi, Paul L Prather, Laura P James, Anna Radominska-Pandya, Jeffery H Moran.   

Abstract

"K2/SPICE" products are commonly laced with aminoalkylindole synthetic cannabinoids (i.e., JWH-018 and JWH-073) and are touted as "legal" marijuana substitutes. Here we validate a liquid chromatography-tandem mass spectrometry (LC-MS/MS) method for measuring urinary concentrations of JWH-018, JWH-073, and several potential metabolites of each. The analytical procedure has high capacity for sample throughput and does not require solid phase or liquid extraction. Evaluation of human urine specimens collected after the subjects reportedly administered JWH-018 or a mixture of JWH-018 and JWH-073 provides preliminary evidence of clinical utility. Two subjects that consumed JWH-018 primarily excreted glucuronidated conjugates of 5-(3-(1-naphthoyl)-1H-indol-1-yl)-pentanoic acid (>30 ng/mL) and (1-(5-hydroxypentyl)-1H-indol-3-yl)(naphthalene-1-yl)-methanone (>50 ng/mL). Interestingly, oxidized metabolites of both JWH-018 and JWH-073 were detected in these specimens, suggesting either metabolic demethylation of JWH-018 to JWH-073 or a nonreported, previous JWH-073 exposure. Metabolic profiles generated from a subject who consumed a mixture of JWH-018 and JWH-073 were similar to profiles generated from subjects who presumably consumed JWH-018 exclusively. Oxidized metabolites of JWH-018 and JWH-073 were of the same pattern, but JWH-018 metabolites were excreted at lower concentrations. These results begin clinically validating the LC-MS/MS assay for detecting and quantifying aminoalkylindole metabolites. Full validation awaits further testing.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21506519      PMCID: PMC3105467          DOI: 10.1021/ac2005636

Source DB:  PubMed          Journal:  Anal Chem        ISSN: 0003-2700            Impact factor:   6.986


  12 in total

1.  Warning: legal synthetic cannabinoid-receptor agonists such as JWH-018 may precipitate psychosis in vulnerable individuals.

Authors:  Susanna Every-Palmer
Journal:  Addiction       Date:  2010-10       Impact factor: 6.526

2.  Use of high-resolution accurate mass spectrometry to detect reported and previously unreported cannabinomimetics in "herbal high" products.

Authors:  Simon Hudson; John Ramsey; Les King; Sarah Timbers; Steve Maynard; Paul I Dargan; David M Wood
Journal:  J Anal Toxicol       Date:  2010-06       Impact factor: 3.367

3.  'Spice' and other herbal blends: harmless incense or cannabinoid designer drugs?

Authors:  Volker Auwärter; Sebastian Dresen; Wolfgang Weinmann; Michael Müller; Michael Pütz; Nerea Ferreirós
Journal:  J Mass Spectrom       Date:  2009-05       Impact factor: 1.982

4.  Investigating a not-so-natural high.

Authors:  Christine Piggee
Journal:  Anal Chem       Date:  2009-05-01       Impact factor: 6.986

5.  Identification of a cannabinoid analog as a new type of designer drug in a herbal product.

Authors:  Nahoko Uchiyama; Ruri Kikura-Hanajiri; Nobuo Kawahara; Yuji Haishima; Yukihiro Goda
Journal:  Chem Pharm Bull (Tokyo)       Date:  2009-04       Impact factor: 1.645

6.  The synthetic cannabinoid Spice as a trigger for an acute exacerbation of cannabis induced recurrent psychotic episodes.

Authors:  Helge Müller; Wolfgang Sperling; Martin Köhrmann; Hagen B Huttner; Johannes Kornhuber; Juan-Manuel Maler
Journal:  Schizophr Res       Date:  2010-01-08       Impact factor: 4.939

7.  Development and validation of a liquid chromatography-tandem mass spectrometry method for the quantitation of synthetic cannabinoids of the aminoalkylindole type and methanandamide in serum and its application to forensic samples.

Authors:  Sebastian Dresen; Stefan Kneisel; Wolfgang Weinmann; Ralf Zimmermann; Volker Auwärter
Journal:  J Mass Spectrom       Date:  2011-01-24       Impact factor: 1.982

8.  Detection of JWH-018 metabolites in smoking mixture post-administration urine.

Authors:  Tim Sobolevsky; Ilya Prasolov; Grigory Rodchenkov
Journal:  Forensic Sci Int       Date:  2010-04-28       Impact factor: 2.395

9.  Monitoring of herbal mixtures potentially containing synthetic cannabinoids as psychoactive compounds.

Authors:  Sebastian Dresen; Nerea Ferreirós; Michael Pütz; Folker Westphal; Ralf Zimmermann; Volker Auwärter
Journal:  J Mass Spectrom       Date:  2010-10       Impact factor: 1.982

10.  Spice: a never ending story?

Authors:  Rainer Lindigkeit; Anja Boehme; Ina Eiserloh; Maike Luebbecke; Marion Wiggermann; Ludger Ernst; Till Beuerle
Journal:  Forensic Sci Int       Date:  2009-07-08       Impact factor: 2.395

View more
  36 in total

1.  A major glucuronidated metabolite of JWH-018 is a neutral antagonist at CB1 receptors.

Authors:  Kathryn A Seely; Lisa K Brents; Anna Radominska-Pandya; Gregory W Endres; Gregory S Keyes; Jeffery H Moran; Paul L Prather
Journal:  Chem Res Toxicol       Date:  2012-03-15       Impact factor: 3.739

2.  Monohydroxylated metabolites of the K2 synthetic cannabinoid JWH-073 retain intermediate to high cannabinoid 1 receptor (CB1R) affinity and exhibit neutral antagonist to partial agonist activity.

Authors:  Lisa K Brents; Anna Gallus-Zawada; Anna Radominska-Pandya; Tamara Vasiljevik; Thomas E Prisinzano; William E Fantegrossi; Jeffery H Moran; Paul L Prather
Journal:  Biochem Pharmacol       Date:  2012-01-18       Impact factor: 5.858

3.  Severe toxicity following synthetic cannabinoid ingestion.

Authors:  J Lapoint; L P James; C L Moran; L S Nelson; R S Hoffman; J H Moran
Journal:  Clin Toxicol (Phila)       Date:  2011-10       Impact factor: 4.467

Review 4.  Here today, gone tomorrow…and back again? A review of herbal marijuana alternatives (K2, Spice), synthetic cathinones (bath salts), kratom, Salvia divinorum, methoxetamine, and piperazines.

Authors:  Christopher D Rosenbaum; Stephanie P Carreiro; Kavita M Babu
Journal:  J Med Toxicol       Date:  2012-03

Review 5.  Spice drugs are more than harmless herbal blends: a review of the pharmacology and toxicology of synthetic cannabinoids.

Authors:  Kathryn A Seely; Jeff Lapoint; Jeffery H Moran; Liana Fattore
Journal:  Prog Neuropsychopharmacol Biol Psychiatry       Date:  2012-04-26       Impact factor: 5.067

6.  K2 toxicity: fatal case of psychiatric complications following AM2201 exposure.

Authors:  Amy L Patton; Krishna C Chimalakonda; Cindy L Moran; Keith R McCain; Anna Radominska-Pandya; Laura P James; Charles Kokes; Jeffery H Moran
Journal:  J Forensic Sci       Date:  2013-07-03       Impact factor: 1.832

Review 7.  "Herbal incense": designer drug blends as cannabimimetics and their assessment by drug discrimination and other in vivo bioassays.

Authors:  Torbjörn U C Järbe; Roger S Gifford
Journal:  Life Sci       Date:  2013-07-25       Impact factor: 5.037

Review 8.  Distinct pharmacology and metabolism of K2 synthetic cannabinoids compared to Δ(9)-THC: mechanism underlying greater toxicity?

Authors:  William E Fantegrossi; Jeffery H Moran; Anna Radominska-Pandya; Paul L Prather
Journal:  Life Sci       Date:  2013-09-29       Impact factor: 5.037

9.  Qualitative confirmation of 9 synthetic cannabinoids and 20 metabolites in human urine using LC-MS/MS and library search.

Authors:  Ariane Wohlfarth; Karl B Scheidweiler; Xiaohong Chen; Hua-fen Liu; Marilyn A Huestis
Journal:  Anal Chem       Date:  2013-03-18       Impact factor: 6.986

10.  Cytochrome P450-mediated oxidative metabolism of abused synthetic cannabinoids found in K2/Spice: identification of novel cannabinoid receptor ligands.

Authors:  Krishna C Chimalakonda; Kathryn A Seely; Stacie M Bratton; Lisa K Brents; Cindy L Moran; Gregory W Endres; Laura P James; Paul F Hollenberg; Paul L Prather; Anna Radominska-Pandya; Jeffery H Moran
Journal:  Drug Metab Dispos       Date:  2012-08-17       Impact factor: 3.922

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.